Genomic Biomarker Discovery for Immunotherapy Response Prediction

Cancer Systems Biology › Cancer Genomics Mutation Burden Analysis

Genomic Biomarker Discovery for Immunotherapy Response Prediction

Interns will correlate mutation burden metrics with immune checkpoint inhibitor response outcomes in published cancer cohorts. They will explore how mutational load, neoantigen density, and specific mutational signatures predict immunotherapy efficacy and identify novel genomic predictors of patient treatment response.

Choose your preferences above

Select Type, Mode and Duration to view available internship titles and fees.